Publicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (24)

2022

  1. Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis

    Pharmaceutics, Vol. 14, Núm. 3

  2. Pharmacometric characterization of entero-hepatic circulation processes of orally administered formulations of amiodarone under complex binding kinetics

    European Journal of Pharmaceutical Sciences, Vol. 174

  3. Quantitative assessment of the exposure–efficacy relationship of glucocerebrosidase using Markovian elements in Gaucher patients treated with enzyme replacement therapy

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 6, pp. 2727-2737

2021

  1. Evaluation of ABC gene polymorphisms on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal patients: Implications for dosing recommendations

    British Journal of Clinical Pharmacology, Vol. 87, Núm. 3, pp. 905-915

  2. Farmacoterapia personalizada en oncología: Aplicación de criterios farmacocinéticos-farmacodinámicos

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 7, pp. 45-55

  3. Physico-Chemical Stability of Admixtures of Vinflunine Used in Clinical Practice

    Journal of Pharmaceutical Sciences, Vol. 110, Núm. 7, pp. 2687-2693

2018

  1. Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

    Basic and Clinical Pharmacology and Toxicology, Vol. 123, Núm. 1, pp. 65-71

2017

  1. Antibiotic-loaded Bone Cement as Prophylaxis in Total Joint Replacement

    Orthopaedic Surgery, Vol. 9, Núm. 4, pp. 331-341

  2. Bioactivity of Ceftazidime and Fluconazole Included in Polymethyl Methacrylate Bone Cement for Use in Arthroplasty

    Journal of Arthroplasty, Vol. 32, Núm. 10, pp. 3126-3133.e1

  3. Population pharmacokinetics of lenalidomide in multiple myeloma patients

    Cancer Chemotherapy and Pharmacology, Vol. 79, Núm. 1, pp. 189-200

2016

  1. A Wide Linearity Range Method for the Determination of Lenalidomide in Plasma by High-Performance Liquid Chromatography: Application to Pharmacokinetic Studies

    Journal of Laboratory Automation, Vol. 21, Núm. 6, pp. 806-810

  2. A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patients

    International Journal of Antimicrobial Agents, Vol. 47, Núm. 3, pp. 184-194

  3. Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment

    Clinical Pharmacokinetics, Vol. 55, Núm. 9, pp. 1103-1113

2015

  1. Evaluación de la bioactividad de ciprofloxacino y vancomicina incorporados en cementos óseos poliacrílicos

    Anales de la Real Academia Nacional de Farmacia, Vol. 81, Núm. 3, pp. 239-246

  2. Impact of nutritional status on the pharmacokinetics of erlotinib in rats

    Biopharmaceutics and Drug Disposition, Vol. 36, Núm. 6, pp. 373-384

2011

  1. Effect of age on systemic exposure and haematological toxicity of carboplatin in advanced non-small cell lung cancer patients

    Basic and Clinical Pharmacology and Toxicology, Vol. 109, Núm. 6, pp. 457-464

  2. Impact of nutritional status on the oral bioavailability of leucine administered to rats as part of a standard enteral diet

    Clinical Nutrition, Vol. 30, Núm. 4, pp. 517-523

  3. In Situ Study of the Effect of Naringin, Talinolol and Protein-Energy Undernutrition on Intestinal Absorption of Saquinavir in Rats

    Basic and Clinical Pharmacology and Toxicology, Vol. 109, Núm. 4, pp. 245-252

  4. Modelo de desnutrición animal para la evaluación de estudios de farmacocinetica

    Nutricion Hospitalaria, Vol. 26, Núm. 6, pp. 1296-1304

  5. Perfil de toxicidad y adherencia del esquema farmacoterapéutico gemcitabina-carboplatino en cáncer de pulmón no microcítico

    Farmacia Hospitalaria, Vol. 35, Núm. 6, pp. 298-304